← All patents

US20200239969A1

Methods and compositions for use of trex2 as diagnostic and prognostic marker …

University of Texas System

Abstract

Provided here are methods of assessing prognosis for a patient who has been diagnosed with a type of cancer by measuring TREX2 mRNA expression in a biological sample from the patient, comparing the TREX2 mRNA expression in the biological sample to a reference value, and providing a prognosis based …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Edward Paul Hasty
Priority date
October 16, 2017
Filing date
October 16, 2018
Publication date
July 30, 2020
Language
en
Metadata fetched
August 29, 2026 00:27